logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10653671 B1

PDFFull Text
Date of Patent:
May. 19, 2020

Filed:

Mar. 15, 2013

Topical pharmaceutical compositions for treatment of skin damage

Applicant:

S.l.a. Pharma Ag, Liestal, CH;

Inventors:

David Nigel Armstrong, Lawrenceveille, GA (US);

Justin Slagel, Watford, GB;

Assignee:

S.L.A. PHARMA, AG, Liestal, CH;

Attorneys:

Tristan A. Fuierer

Marianne Fuierer

Olive Law Group, PLLC

Primary Examiner:

Layla Soroush

Int. Cl.
CPC ...
A01N 45/00 (2006.01); A61K 31/56 (2006.01); A61K 31/4164 (2006.01); A61K 9/00 (2006.01); A61K 31/192 (2006.01); A61K 31/24 (2006.01); A61K 31/245 (2006.01); A61K 31/355 (2006.01); A61K 31/407 (2006.01); A61K 31/4166 (2006.01); A61K 31/545 (2006.01); A61K 31/573 (2006.01); A61K 31/60 (2006.01); A61K 31/65 (2006.01); A61K 33/30 (2006.01); A61K 45/06 (2006.01); A61K 9/06 (2006.01); A61K 47/06 (2006.01); A61K 47/44 (2017.01);
U.S. Cl.
CPC ...
A61K 31/4164 (2013.01); A61K 9/0014 (2013.01); A61K 9/0031 (2013.01); A61K 9/06 (2013.01); A61K 31/192 (2013.01); A61K 31/24 (2013.01); A61K 31/245 (2013.01); A61K 31/355 (2013.01); A61K 31/407 (2013.01); A61K 31/4166 (2013.01); A61K 31/545 (2013.01); A61K 31/573 (2013.01); A61K 31/60 (2013.01); A61K 31/65 (2013.01); A61K 33/30 (2013.01); A61K 45/06 (2013.01); A61K 47/06 (2013.01); A61K 47/44 (2013.01);
Abstract

A topical composition comprising about 5 wt % to about 12.5 wt % of metronidazole or a pharmacologically acceptable salt thereof in a non-aqueous vehicle. The composition may be used in the treatment of skin damage due to inflammatory skin conditions; thermal, chemical or electrical burns; infections or radiation treatment. One advantage of the composition is that topical administration of metronidazole results in a primarily local effect, and thus, side effects observed from systemic administration are avoided.

Find Patent Forward Citations

Armstrong, David. (2020). Topical pharmaceutical compositions for treatment of skin damage (U.S. Patent No. 10653671). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10653671

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…